- Home
- PDO vs TXG Comparison
PDO vs TXG Comparison
Compare PDO & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDO
- TXG
- Stock Information
- Founded
- PDO 2020
- TXG 2012
- Country
- PDO United States
- TXG United States
- Employees
- PDO N/A
- TXG N/A
- Industry
- PDO Trusts Except Educational Religious and Charitable
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- PDO Finance
- TXG Industrials
- Exchange
- PDO Nasdaq
- TXG Nasdaq
- Market Cap
- PDO 1.8B
- TXG 1.6B
- IPO Year
- PDO N/A
- TXG 2019
- Fundamental
- Price
- PDO $13.83
- TXG $15.93
- Analyst Decision
- PDO
- TXG Buy
- Analyst Count
- PDO 0
- TXG 13
- Target Price
- PDO N/A
- TXG $14.50
- AVG Volume (30 Days)
- PDO 520.0K
- TXG 3.3M
- Earning Date
- PDO 01-01-0001
- TXG 11-06-2025
- Dividend Yield
- PDO 11.80%
- TXG N/A
- EPS Growth
- PDO N/A
- TXG N/A
- EPS
- PDO N/A
- TXG N/A
- Revenue
- PDO N/A
- TXG $641,814,000.00
- Revenue This Year
- PDO N/A
- TXG $2.07
- Revenue Next Year
- PDO N/A
- TXG N/A
- P/E Ratio
- PDO N/A
- TXG N/A
- Revenue Growth
- PDO N/A
- TXG 1.92
- 52 Week Low
- PDO $10.65
- TXG $6.78
- 52 Week High
- PDO $13.31
- TXG $17.70
- Technical
- Relative Strength Index (RSI)
- PDO 42.58
- TXG 62.12
- Support Level
- PDO $13.85
- TXG $12.80
- Resistance Level
- PDO $13.99
- TXG $17.70
- Average True Range (ATR)
- PDO 0.09
- TXG 0.97
- MACD
- PDO 0.00
- TXG 0.30
- Stochastic Oscillator
- PDO 43.10
- TXG 66.79
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).